scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
johngtudor
- 08 Dec 2004 11:36
- 1615 of 2372
Seymour: Lucien Mears is a well known Bear Raider.
ssanebs: Yes.
Seymour Clearly
- 08 Dec 2004 12:36
- 1616 of 2372
Hmm, I must be living in a cloud - have heard of Simon Caukwell but not LM. Live and learn.
johngtudor
- 08 Dec 2004 12:53
- 1617 of 2372
Lucien Mears used to work with Simon Caukwell if that helps. Odd that as BPRG SP stabilises around 70p and starts to show a tendency to rise, we have the Lucien rumour hitting the media wires! The iii live webcast should be interesting and we will have to see how the SP responds.
drunker50
- 08 Dec 2004 16:05
- 1618 of 2372
41 mill shares sold under 1mill bought in seo summat up i think
superrod
- 08 Dec 2004 16:59
- 1619 of 2372
drunker50
it would seem that the 40million sell was expected and priced in. at present i dont hold either bprg or seo
Janus
- 08 Dec 2004 17:17
- 1620 of 2372
I wonder when the good Judge Floyd will deliver his verdict ?
Maggot
- 08 Dec 2004 17:25
- 1621 of 2372
I'm in from 117 and 75. Perhaps time to get out and watch for 45p.
scotinvestor
- 08 Dec 2004 18:30
- 1622 of 2372
BPRG is a long term hold IMHO. I'm at a bit of a loss at present and maybe BPRG may plummet in near future. But in 3 or 4 years time, i'm sure this share will be several s. A lot of people commenting on this share appear to be traders and not long term investors. I only buy for m,edium to long term growth just like Warren Buffett.
Big Al
- 08 Dec 2004 20:04
- 1623 of 2372
Warren Buffett wouldn't be seen dead buying BPRG, trust me!
;-))
It's now a traders' share like it or not.
moneyplus
- 08 Dec 2004 20:45
- 1624 of 2372
Long term investing is fine for companies like PAY or NLR with rising trends and good growth established but you could grow barnacles waiting around for this one. Grab a profit when you're up!!
Janus
- 09 Dec 2004 08:41
- 1625 of 2372
Big match result today 10 00 AM
daves dazzlers
- 09 Dec 2004 08:47
- 1626 of 2372
I am ready for another scoop,if it bombs.
AdieH
- 09 Dec 2004 08:58
- 1627 of 2372
Janus, Is that the Court Case results at 10am... Don't think the 41m sell yest of SEO had anything to do with rumours of court case results, seems to be something to do with recent share options for directors etc.
Janus
- 09 Dec 2004 09:10
- 1628 of 2372
AdieH, Yes court case today, should just be a case of him handing letters out
COURT 55
Before MR C FLOYD QC (Sitting as a Deputy Judge of the Chancery Division)
Thursday, 9th December 2004
At 10 o'clock
Unrobed
For Judgment
PATENTS COURT
Application
Stanelo [sic] Fibre Optics Ltd v Bioprogress Technology Ltd
AdieH
- 09 Dec 2004 09:12
- 1629 of 2372
Many thanks Janus.
SuperBrugha
- 09 Dec 2004 10:44
- 1630 of 2372
Any news???
SuperBrugha
- 09 Dec 2004 10:50
- 1631 of 2372
And the winner is?
Surely it can't take old crusty Floyd to give us the nod????
What frenzy is playing on advfn?
Janus
- 09 Dec 2004 11:19
- 1632 of 2372
looks like the winner is BPRG not sure on the details yet
Kivver
- 09 Dec 2004 11:53
- 1633 of 2372
despite all the negative comments the sp seems to be holding up.
Janus
- 09 Dec 2004 12:03
- 1634 of 2372
Damages assessment to proceed in High Court case
BioProgress plc (AIM: BPRG; NASDAQ: BPRG) advises that the UK Patents Court has
rejected the attempt by Stanelco Fibre Optics Limited ("Stanelco") to re-open
the case, and has awarded the relevant legal costs to BioProgress. Stanelco has
been granted permission to appeal this latest decision but this will not hold up
the process for assessing the damages to be paid by Stanelco to the Company's
wholly owned subsidiary BioProgress Technology Limited.
Stanelco must now comply with the Court's previous order and disclose all
material details relevant to the misuse of the information previously given to
them in confidence by BioProgress. These details will allow BioProgress to
formulate its damages claim which will then be assessed by the Court.
Graham Hind, Chief Executive of BioProgress, said: "We are clearly pleased that
the Court has quickly rejected Stanelco's application for a re-trial on the
single issue of breach of confidence, and has stuck by its previous judgment.
This decision further vindicates the position we have taken throughout these
proceedings."